Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.14%
SPX
+0.06%
IXIC
+0.42%
FTSE
+0.14%
N225
+1.45%
AXJO
-0.24%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Signals

LSTA
Lisata Therapeutics
about 1 month ago
LSTA beat EPS expectations by 18.55%
0.00%
📡️ Health Care
LSTA
Lisata Therapeutics
about 1 month ago
LSTA has been in the news 313% more than usual
-2.67%
📡️ Health Care
LSTA
Lisata Therapeutics
about 2 months ago
LSTA has been in the news 333% more than usual
-2.60%
📡️ Health Care
LSTA
Lisata Therapeutics
3 months ago
LSTA has been in the news 313% more than usual
8.58%
📡️ Health Care
LSTA
Lisata Therapeutics
3 months ago
LSTA has been in the news 409% more than usual
-1.12%
📡️ Health Care
LSTA
Lisata Therapeutics
4 months ago
LSTA has been in the news 324% more than usual
5.60%
📡️ Health Care
LSTA
Lisata Therapeutics
5 months ago
LSTA has been in the news 350% more than usual
7.17%
📡️ Health Care
LSTA
Lisata Therapeutics
5 months ago
LSTA has been in the news 357% more than usual
16.51%
📡️ Health Care
LSTA
Lisata Therapeutics
6 months ago
LSTA beat EPS expectations by 29.05%
0.00%
📡️ Health Care
LSTA
Lisata Therapeutics
7 months ago
Analysts think LSTA stock price could increase by 486%
-11.88%
📡️ Health Care
LSTA
Lisata Therapeutics
8 months ago
LSTA has been in the news 311% more than usual
-31.66%
📡️ Health Care
LSTA
Lisata Therapeutics
10 months ago
Analysts think LSTA stock price could increase by 403%
10.21%
📡️ Health Care
Join our newsletter to keep up to date with us!
Stocks
Health Care
lsta
Lisata Therapeutics
NASDAQ: LSTA
+0.06 (+2.84%)
2.17
USD
At close at Sep 08, 17:40 UTC
Summary
News
Signals
Benchmarks
Financials